Solar Urticaria
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Omalizumab in Severe and Refractory Solar Urticaria (NCT02262130) | Centre Hospitalier Universitaire de Besancon | 2014-09-30 |
| Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria (NCT01360658) | Centre Hospitalier Universitaire de Besancon | 2011-06-01 |
| Phase II Solar Urticaria (SU) Pilot Study (NCT00859534) | Clinuvel Pharmaceuticals Limited | 2008-12-01 |
Track Solar Urticaria automatically
Every clearance here is in the API, with alerts when new ones post.